var genes, PfEMP1 and the human host

Kirsten Flick1, Qijun Chen

  • 1Microbiology and Tumour Biology Centre (MTC), Karolinska Institutet and Swedish Institute for Infectious Disease Control, Box 280, SE-171 77 Stockholm, Sweden.

Insights

Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) uses antigenic variation to evade the host immune system. Understanding PfEMP1 and var gene recombination is key to developing malaria treatments and preventing severe disease.

Area of Science:

  • Malariology
  • Immunology
  • Genetics

Background:

  • Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a key virulence factor encoded by var genes.
  • PfEMP1 mediates parasite adhesion and immune evasion through antigenic variation of infected red blood cells.
  • Sequestration of infected red blood cells contributes to severe malaria pathology.

Purpose of the Study:

  • To review recent analyses of var genes within the P. falciparum genome.
  • To explore the significance of genome recombination in generating parasite virulence diversity.
  • To highlight the need for further immunological studies on PfEMP1-host interactions.

Main Methods:

  • Genomic analysis of var genes in P. falciparum.
  • Biochemical and immunological studies of PfEMP1.
  • Epidemiological data analysis.
  • Review of recent genetic and functional studies.

Main Results:

  • Significant advancements in understanding var genes and PfEMP1 through diverse studies.
  • The P. falciparum genome sequence provides a platform for dissecting PfEMP1 functions.
  • Genome recombination plays a crucial role in the diversity of parasite virulence.

Conclusions:

  • PfEMP1 and var gene variation are central to P. falciparum virulence and immune evasion.
  • Further research into PfEMP1-host interactions is essential for malaria control.
  • Genomic insights are critical for understanding and combating malaria.

Related Concept Videos

Organization of Genes02:07

Organization of Genes

Overview
73.7K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.7K
Gene Flow02:39

Gene Flow

Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
38.1K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
10.0K
Gene Conversion02:08

Gene Conversion

Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
10.7K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K